ResMed has launched a rebrand to unify its portfolio and reflect its increasing direct-to-consumer engagement.
Zacks Investment Research on MSN6h
Eli Lilly Rises 7.5% YTD: Time to Buy, Sell or Hold the Stock?Eli Lilly and Company’s LLY shares dipped almost 5% on Monday after rival Novo Nordisk NVO announced disappointing data from ...
Q4 2024 Results Conference Call March 10, 2025 4:30 PM ETCompany ParticipantsJustin Schreiber - Chairman and Chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback